Abstract
Despite a tremendous increase of direct oral anticoagulants (DOACs) prescriptions in recent years, only few data are available analysing prescribers' adherence to Summary of Product Characteristics (SmPC). We aimed to assess adherence to registered indications, contraindications, special warnings/precautions, and potential drug-drug interactions for three DOAC compounds (dabigatran, rivaroxaban, apixaban) in
... read more